Influence of the Vitreomacular Interface on Outcomes of Ranibizumab Therapy in Neovascular Age-related Macular DegenerationUlrike Mayr-Sponer, Ursula Schmidt‐Erfurth, Michael Kundi et al.|Ophthalmology|2013Cited by 81